In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 32 for your search:
Drug:  darbepoetin alfa
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2612-2277, NCT00122720

2.

Phase: Phase IV
Type: Health services research, Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR002455, EPOCAN4015, NCT00264108

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 04/Q1907/94, NCT00234143

4.

Phase: Phase III, Phase II
Type: Supportive care
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: 2005-005658-37, LM: 2612-3148, Ethical: 20060074, Data Protection: 2005-41-6015, NCT00381836

5.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 16 to 69
Sponsor: Other
Protocol IDs: TJE0301, NCT00557817

6.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20010101, UCLA-0201098, NCI-G02-2112, AMGEN-200101101, NCT00046982, NCT00038064

7.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000333213, P30CA016042, UCLA-0306021, AMGEN-20030125, NCT00070382

8.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20010145, NCT00119613

9.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 66 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: LNH03-6B, NCT00144755

10.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20040156, NCT00135317

11.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: Geriatric
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GCLLSG-CLL9, EU-20561, AMGEN-GCLLSG-CLL9, EUDRACT-2005-003014-15, NCT00281892

12.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 20 to 74
Sponsor: Pharmaceutical / Industry
Protocol IDs: KRN321-SC/05-A54, NCT00344409

13.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000593480, P30CA015083, MC04CC, NCI-2009-01226, 1713-05, MAYO-MC04CC, NCT00661999

14.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20010103, UCLA-0403046-01, AMGEN-20010103, NCT00091858

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: HEMMDS0001, 13536, NCT00230321

16.

Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0111006, AMGEN-20010162, NCI-G02-2071, NCT00039247

17.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: 02-090, MSKCC-02090, NCT00058422

18.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000350089, U10CA031946, CALGB-30303, NCT00077311

19.

Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 01/155A, NCT00039884

20.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20030204, NCT00095277

21.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20040262, NCT00144131

22.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: jth_004, NCT00204633

23.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20040232, NCT00239239

24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20040137, NCT00261313

25.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 20 to 74
Sponsor: Pharmaceutical / Industry
Protocol IDs: KRN321-SC/05-A55, NCT00359840
1   
New Search